SBM's Rs 470M Hotel Loan Under FCCC Scrutiny

The Rs 470 million facility extended by State Bank of Mauritius to Sanjiv Ramdanee's hotel operation continues to raise questions about what the financing actually was, and what it financed. The Financial Crimes Commission has brought provisional charges of conspiracy, alleging a deliberate overvaluation of the business plan and possible diversion of funds toward private events. Yet the documented record shows the file cleared the bank's formal administrative gates: the credit was approved by SBM's Management Credit Forum on the basis of financial projections prepared for post-pandemic restructuring. Ramdanee rejects the allegations and was released on bail without objection from the authorities. The investigation, however, is running into contradictions of both chronology and substance. Despite the diversion allegations, the financial tracing exercise has not been completed by the authorities, which means there is no documented evidence on the end use of the funds. The file also lacks independent third-party audits capable of determining whether the property valuations reflected a fraudulent manoeuvre or a professional disagreement over forecasts in a hotel sector devastated by the health crisis. That distinction matters. An inflated projection in a distressed sector is not, on its own, a finding of fraud, and no audit currently on file settles the question either way. Clarifying these grey zones requires attention to two specific sets of records. The first is the actual disbursement flows, which would establish whether the funds were strictly allocated to renovations of the complex or were redirected through intermediary entities or commercial arrangements. The second is the minutes of the bank's credit committee, which would show how the risk was assessed and by whom. A further unresolved question is whether the valuation underpinning the business plan rested on standard market indicators or was adjusted to secure excess capital. Meanwhile, the public interest issue concerns the transparency of institutional credit-granting processes for large exposures during an economic crisis. Accountability remains open: which directors evaluated and validated these risks, on what documentation, and against what internal limits. The final determination will turn on the financial records, the approvals and the banking traces that explain how the decision was made and who ultimately benefited from it. Until the tracing exercise and an independent valuation review are completed, the case remains a matter of allegations set against a formally compliant approval trail, and the gap between the two is precisely where the outstanding questions sit.